CSG Midwest
As the Midwest’s legislators look for ways to reduce infant mortality, prevent maternal deaths, and improve long-term outcomes for mothers and children, one policy option is to invest in home visiting.
The idea of bringing preventive services and resources to the place where families live has captured more interest, and funding, during this decade.
In 2010, the U.S. Congress created the Maternal, Infant and Early Childhood Home Visiting Program, and every year since then, states have received federal dollars to provide home services for vulnerable or at-risk families.
CSG Midwest
Wisconsin Gov. Scott Walker signed 11 bills into law in July that seek to address myriad facets of the state’s opioid crisis. The bills were the product of a special session held earlier in the year.
CSG Midwest
Wisconsin Gov. Scott Walker signed 11 bills into law in July that seek to address myriad facets of the state’s opioid crisis. The bills were the product of a special session held earlier in the year.

Since 1999, the number of overdose deaths involving opioids (including prescription opioids and heroin) has quadrupled, accounting for six out of every 10 drug overdose deaths. Current estimates show that 91 Americans die each day from an opioid overdose, according to the Centers for Disease Control and Prevention, or CDC1.

Since 1999, the number of overdose deaths involving opioids (including prescription opioids and heroin) has quadrupled, accounting for six out of every 10 drug overdose deaths. Current estimates show that 91 Americans die each day from an opioid overdose, according to the Centers for Disease Control and Prevention, or CDC. Opioid deaths are increasing at alarming rates across the states. And while state policies to reduce the availability of prescription opioids are working to reduce overdose deaths, heroin and synthetic opioid overdoses are beginning to climb.

Over the years, substance abuse trends in the states have shift from one drug to another as new policy solutions make previously abused drugs more scarce. Over the past decade, gabapentin has emerged as a drug of concern. Gabapentin, the generic for Neurontin, is a medication that was approved by the FDA in 1993 and is approved to treat epilepsy and nerve pain caused by shingles. The IMS Institute...

Drug abuse is an ever-growing epidemic in the United States. In a series of research briefs, CSG will examine the effects of drug abuse on the states through incarceration, treatment and the workforce.

The latest version of the Senate’s Better Care Reconciliation Act, or BCRA, was released July 20, 2017. According to the CBO analysis, the new version of the BCRA would reduce federal deficits by $420 billion over the 2017-2026 period, the net result of a direct spending decrease of $903 billion partially offset by a $483 billion decrease in revenues. Of special interest to states, the reduction in Medicaid spending is $772 billion, or 85 percent of the reduced spending, directly impacting states’ budgets. The effects of the bill on the number of uninsured is little changed from the earlier version. In 2018, 15 million more people would be uninsured than under current law and would reach 22 million in 2026.

On June 8, 2017, the Food and Drug Administration, or FDA, publicly requested that Endo Pharmaceuticals remove their drug, Opana ER, from the market. The agency stated that the benefits of the medication no longer outweighs the risks. According to the FDA, there has been a shift in abuse that has seen an increase in crushing, snorting and injecting the medication. This increase in injection abuse has also seen an increase in HIV and Hepatitis C...

The Centers for Disease Control and Prevention, or CDC, estimates that 91 Americans die each day from an opioid overdose. The opioid epidemic is one of the biggest public health challenges in the United States today, leading to higher drug abuse rates, increasing health care costs and imposing additional stress on state budgets. Three new reports released in June 2017 demonstrate the growing need for solutions.

Pages